China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid sensing and drives resistance to STING agonists, with an existing drug, DFMO, restoring pathway activity and antitumor responses.
This article was originally published on MedicalXpress.com

